Gujarat Inject Kerala Ltd schedules board meeting on May 20, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Meeting will consider standalone financial results along with statutory auditors' report as per SEBI LODR Regulation 29(1)(a).
Whole-time director Murli Shivshankaran Nair signed the regulatory filing submitted to BSE on May 15, 2026.